Moscow, Russia (August, 13 2007) -Quantum announced today a collaboration with MOLECMO Nanobiotechnologies, a drug discovery company.
The collaboration is aimed at application of Quantum’ industry leading technology to anti-viral drug discovery project led by MOLECMO. The financial terms of the agreement were not disclosed.
About Quantum.
Quantum is a drug discovery company based in Moscow, Russia specializing in small molecule screening and design through the use of its proprietary technology platform.
About MOLECMO.
MOLECMO is an antiviral drug discovery company based in Cambridge, Massachusetts in the heart of the biotechnology circle, proximal to world class research institutes like Harvard and MIT, famed Boston Hospitals and leading Pharmaceutical firms.

Related posts:

1. Quantum announce collaboration with University of Colorado at Boulder
2. Quantum and Institute of Pulmonology entered COPD drug discovery collaboration.
3. HIV-1 integrase drug discovery collaboration
4. Quantum and Otechestvennye Lekarstva OJSC entered drug discovery collaboration.
5. Quantum and Tibotec Pharmaceuticals enter antiviral drug discovery collabortaion.